Voyager Therapeutics Inc (VYGR)
8.94
+0.13
(+1.48%)
USD |
NASDAQ |
May 06, 16:00
9.00
+0.06
(+0.67%)
Pre-Market: 09:09
Voyager Therapeutics Shareholders Equity (Quarterly): 236.32M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 236.32M |
| September 30, 2023 | 176.22M |
| June 30, 2023 | 199.03M |
| March 31, 2023 | 216.96M |
| December 31, 2022 | 59.02M |
| September 30, 2022 | 79.82M |
| June 30, 2022 | 60.05M |
| March 31, 2022 | 75.93M |
| December 31, 2021 | 95.06M |
| September 30, 2021 | 87.42M |
| June 30, 2021 | 110.54M |
| March 31, 2021 | 136.21M |
| December 31, 2020 | 154.32M |
| September 30, 2020 | 166.24M |
| June 30, 2020 | 76.88M |
| March 31, 2020 | 79.76M |
| December 31, 2019 | 99.51M |
| September 30, 2019 | 108.16M |
| Date | Value |
|---|---|
| June 30, 2019 | 118.40M |
| March 31, 2019 | 100.69M |
| December 31, 2018 | 46.45M |
| September 30, 2018 | 65.59M |
| June 30, 2018 | 81.97M |
| March 31, 2018 | 98.29M |
| December 31, 2017 | 134.05M |
| September 30, 2017 | 85.21M |
| June 30, 2017 | 105.29M |
| March 31, 2017 | 122.70M |
| December 31, 2016 | 135.92M |
| September 30, 2016 | 149.12M |
| June 30, 2016 | 155.70M |
| March 31, 2016 | 163.60M |
| December 31, 2015 | 169.07M |
| September 30, 2015 | 101.72M |
| June 30, 2015 | 104.72M |
| December 31, 2014 | 1.149M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
59.02M
Minimum
Dec 2022
236.32M
Maximum
Dec 2023
122.94M
Average
108.16M
Median
Sep 2019
Shareholders Equity (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 700.91M |
| United Therapeutics Corp | 5.338B |
| MEI Pharma Inc | 59.49M |
| Agios Pharmaceuticals Inc | 743.92M |
| Macrogenics Inc | 152.61M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 351.28M |
| Total Liabilities (Quarterly) | 114.96M |
| Current Ratio | 4.956 |